BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 25137025)

  • 1. Somatotropinomas, but not nonfunctioning pituitary adenomas, maintain a functional apoptotic RET/Pit1/ARF/p53 pathway that is blocked by excess GDNF.
    Diaz-Rodriguez E; Garcia-Rendueles AR; Ibáñez-Costa A; Gutierrez-Pascual E; Garcia-Lavandeira M; Leal A; Japon MA; Soto A; Venegas E; Tinahones FJ; Garcia-Arnes JA; Benito P; Angeles Galvez M; Jimenez-Reina L; Bernabeu I; Dieguez C; Luque RM; Castaño JP; Alvarez CV
    Endocrinology; 2014 Nov; 155(11):4329-40. PubMed ID: 25137025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unmasking a new prognostic marker and therapeutic target from the GDNF-RET/PIT1/p14ARF/p53 pathway in acromegaly.
    Chenlo M; Rodriguez-Gomez IA; Serramito R; Garcia-Rendueles AR; Villar-Taibo R; Fernandez-Rodriguez E; Perez-Romero S; Suarez-Fariña M; Garcia-Allut A; Cabezas-Agricola JM; Rodriguez-Garcia J; Lear PV; Alvarez-San Martin RM; Alvarez-Escola C; Bernabeu I; Alvarez CV
    EBioMedicine; 2019 May; 43():537-552. PubMed ID: 30975543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct promoter induction of p19Arf by Pit-1 explains the dependence receptor RET/Pit-1/p53-induced apoptosis in the pituitary somatotroph cells.
    Diaz-Rodriguez E; García-Lavandeira M; Perez-Romero S; Senra A; Cañibano C; Palmero I; Borrello MG; Dieguez C; Alvarez CV
    Oncogene; 2012 Jun; 31(23):2824-35. PubMed ID: 22020338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dependence receptor Ret induces apoptosis in somatotrophs through a Pit-1/p53 pathway, preventing tumor growth.
    Cañibano C; Rodriguez NL; Saez C; Tovar S; Garcia-Lavandeira M; Borrello MG; Vidal A; Costantini F; Japon M; Dieguez C; Alvarez CV
    EMBO J; 2007 Apr; 26(8):2015-28. PubMed ID: 17380130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glial-derived neurotropic factor and RET gene expression in normal human anterior pituitary cell types and in pituitary tumors.
    Japón MA; Urbano AG; Sáez C; Segura DI; Cerro AL; Diéguez C; Alvarez CV
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1879-84. PubMed ID: 11932334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RET signalling provides tumorigenic mechanism and tissue specificity for AIP-related somatotrophinomas.
    Garcia-Rendueles AR; Chenlo M; Oroz-Gonjar F; Solomou A; Mistry A; Barry S; Gaston-Massuet C; Garcia-Lavandeira M; Perez-Romero S; Suarez-Fariña M; Pradilla-Dieste A; Dieguez C; Mehlen P; Korbonits M; Alvarez CV
    Oncogene; 2021 Nov; 40(45):6354-6368. PubMed ID: 34588620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infrequent detectable somatic mutations of the RET and glial cell line-derived neurotrophic factor (GDNF) genes in human pituitary adenomas.
    Yoshimoto K; Tanaka C; Moritani M; Shimizu E; Yamaoka T; Yamada S; Sano T; Itakura M
    Endocr J; 1999 Feb; 46(1):199-207. PubMed ID: 10426588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional role of the RET dependence receptor, GFRa co-receptors and ligands in the pituitary.
    Garcia-Lavandeira M; Diaz-Rodriguez E; Garcia-Rendueles MER; Rodrigues JS; Perez-Romero S; Bravo SB; Alvarez CV
    Front Horm Res; 2010; 38():127-138. PubMed ID: 20616503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of SNARE proteins in human pituitary adenomas: targeted secretion inhibitors as a new strategy for the treatment of acromegaly?
    Garcia EA; Trivellin G; Aflorei ED; Powell M; Grieve J; Alusi G; Pobereskin L; Shariati B; Cudlip S; Roncaroli F; Mendoza N; Grossman AB; Harper EA; Korbonits M
    J Clin Endocrinol Metab; 2013 Dec; 98(12):E1918-26. PubMed ID: 24152687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZAC1 and SSTR2 are downregulated in non-functioning pituitary adenomas but not in somatotropinomas.
    Vieria Neto L; Wildemberg LE; Colli LM; Kasuki L; Marques NV; Moraes AB; Gasparetto EL; Takiya CM; Castro M; Gadelha MR
    PLoS One; 2013; 8(10):e77406. PubMed ID: 24098585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential gene expression of sirtuins between somatotropinomas and nonfunctioning pituitary adenomas.
    Grande IPP; Amorim PVGH; Freire ACTB; Jallad RS; Musolino NR; Cescato VA; da Silva GO; Bronstein MD; Trarbach EB
    Pituitary; 2018 Aug; 21(4):355-361. PubMed ID: 29564694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression analysis of dopamine receptor subtypes in normal human pituitaries, nonfunctioning pituitary adenomas and somatotropinomas, and the association between dopamine and somatostatin receptors with clinical response to octreotide-LAR in acromegaly.
    Neto LV; Machado Ede O; Luque RM; Taboada GF; Marcondes JB; Chimelli LM; Quintella LP; Niemeyer P; de Carvalho DP; Kineman RD; Gadelha MR
    J Clin Endocrinol Metab; 2009 Jun; 94(6):1931-7. PubMed ID: 19293270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of glial cell line-derived neurotrophic factor and neurturin in RET/GFRalpha1-expressing cells.
    Lee RH; Wong WL; Chan CH; Chan SY
    J Neurosci Res; 2006 Jan; 83(1):80-90. PubMed ID: 16294336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoic acid-induced apoptosis of the CHP134 neuroblastoma cell line is associated with nuclear accumulation of p53 and is rescued by the GDNF/Ret signal.
    Takada N; Isogai E; Kawamoto T; Nakanishi H; Todo S; Nakagawara A
    Med Pediatr Oncol; 2001 Jan; 36(1):122-6. PubMed ID: 11464863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT3 upregulation in pituitary somatotroph adenomas induces growth hormone hypersecretion.
    Zhou C; Jiao Y; Wang R; Ren SG; Wawrowsky K; Melmed S
    J Clin Invest; 2015 Apr; 125(4):1692-702. PubMed ID: 25774503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The G691S RET polymorphism increases glial cell line-derived neurotrophic factor-induced pancreatic cancer cell invasion by amplifying mitogen-activated protein kinase signaling.
    Sawai H; Okada Y; Kazanjian K; Kim J; Hasan S; Hines OJ; Reber HA; Hoon DS; Eibl G
    Cancer Res; 2005 Dec; 65(24):11536-44. PubMed ID: 16357163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterization of DLK1/MEG3 locus on chromosome 14q32.2 reveals the differentiation of pituitary neuroendocrine tumors.
    Chen Y; Gao H; Liu Q; Xie W; Li B; Cheng S; Guo J; Fang Q; Zhu H; Wang Z; Wang J; Li C; Zhang Y
    Aging (Albany NY); 2020 Dec; 13(1):1422-1439. PubMed ID: 33472171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the antiapoptotic gene seladin-1 and octreotide-induced apoptosis in growth hormone-secreting and nonfunctioning pituitary adenomas.
    Luciani P; Gelmini S; Ferrante E; Lania A; Benvenuti S; Baglioni S; Mantovani G; Cellai I; Ammannati F; Spada A; Serio M; Peri A
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6156-61. PubMed ID: 16091489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acidic oligosaccharide sugar chain, a marine-derived oligosaccharide, activates human glial cell line-derived neurotrophic factor signaling.
    Wang XJ; Chen XH; Yang XY; Geng MY; Wang LM
    Neurosci Lett; 2007 May; 417(2):176-80. PubMed ID: 17403572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glial cell line-derived neurotrophic factor and its receptor ret is a novel ligand-receptor complex critical for survival response during podocyte injury.
    Tsui CC; Shankland SJ; Pierchala BA
    J Am Soc Nephrol; 2006 Jun; 17(6):1543-52. PubMed ID: 16672314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.